Global X China MedTech ETF logo

Global X China MedTech ETF (2841)

Market Open
13 Aug, 05:02
HKEX HKEX
40. 88
HKD
+0.76
+1.8943%
HKD
92.04M Market Cap
- Div Yield
50 Volume
40.12 HKD
Previous Close
Add Transaction
Day Range
40.88 41
Year Range
33.9 54.26
Want to track 2841 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2841 trading today higher at 40.88 HKD, an increase of 1.8943% from yesterday's close, completing a monthly increase of 12.4931% or 4.54 HKD. Over the past 12 months, 2841 stock lost -8.5868%.
2841 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

2841 Chart

Global X China MedTech ETF (2841) FAQ

What is the stock price today?

The current price is 40.88 HKD.

On which exchange is it traded?

Global X China MedTech ETF is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2841.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 92.04M.

Has Global X China MedTech ETF ever had a stock split?

No, there has never been a stock split.

Global X China MedTech ETF Profile

HKEX Exchange
Hong Kong Country

Overview

The Global X China MedTech ETF is an exchange-traded fund designed specifically to provide investors with strategic access to China's burgeoning medical technology sector. This ETF aligns with the growth trajectory of companies engaged in the innovation, production, and distribution of medical technologies and devices that are essential for healthcare and medical research. With its focus on one of the fastest-evolving healthcare markets globally, the ETF offers a unique investment opportunity. It leverages the rising demand for advanced medical treatments and technologies in China, propelled by an aging population and a growing middle class. This focus not only captures the essence of China's healthcare sector growth but also reflects the broader trends in technological advancements and healthcare reforms sweeping through the country.

Products and Services

The Global X China MedTech ETF provides investors with a comprehensive array of products and services, each targeting distinct aspects of China's medical technology landscape. These include:

  • Diagnostic Technologies: This category comprises companies specializing in the development of tools and services for diagnosing diseases and conditions. Diagnostic advancements enable earlier and more accurate disease detection, significantly impacting treatment outcomes and efficiency in healthcare delivery.
  • Surgical Instruments: Investments in firms focused on crafting precision tools used in surgical operations fall under this segment. Surgical instruments are critical for the evolving landscape of both traditional and minimally invasive surgeries, thus holding a pivotal role in enhancing surgical efficacy and patient recovery times.
  • Robotic Surgery: This sector captures the growing influence of robotics in surgery, spotlighting companies at the forefront of developing robotic systems and solutions that augment the precision, efficiency, and safety of surgical procedures. Robotic surgery represents a leap forward in medical technology, offering minimally invasive options and fostering rapid recovery.
  • Telemedicine: With the integration of telecommunication technologies in healthcare, this segment emphasizes investment in platforms and services enabling remote healthcare services. Telemedicine facilitates accessible and efficient healthcare delivery, particularly in underserved or remote areas, thus expanding the reach and scope of healthcare services.

Contact Information

Address: -
Phone: -